NS1: A corner piece in the dengue pathogenesis puzzle?

Science Translational Medicine

Volumn 7, Issue 304, 2015, Pages

  Thomas, Stephen J ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DENGUE VACCINE; NONSTRUCTURAL PROTEIN 1; TOLL LIKE RECEPTOR 4; VIRUS PROTEIN;

AEDES; APOPTOSIS; ARTICLE; CLINICAL FEATURE; DENGUE; DENGUE VIRUS; DISEASE SEVERITY; ENDOTHELIUM CELL; HOSPITAL ADMISSION; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INFLAMMATION; NONHUMAN; POPULATION GROWTH; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS REPLICATION; ANIMAL; CELL MEMBRANE PERMEABILITY; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; PATHOLOGY; VACCINATION;

ANIMALS; CELL MEMBRANE PERMEABILITY; DENGUE VIRUS; ENDOTHELIAL CELLS; HUMANS; TOLL-LIKE RECEPTOR 4; VACCINATION; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84941243498     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aad1255     Document Type: Article

References (10)

1. S. Bhatt, P. W. Gething, O. J. Brady, J. P. Messina, A. W. Farlow, C. L. Moyes, J. M. Drake, J. S. Brownstein, A. G. Hoen, O. Sankoh, M. F. Myers, D. B. George, T. Jaenisch, G. R. Wint, C. P. Simmons, T. W. Scott, J. J. Farrar, S. I. Hay, The global distribution and burden of dengue. Nature 496, 504-507 (2013).
2. N. Modhiran, D. Watterson, D. A. Muller, A. K. Panetta, D. P. Sester, L. Liu, D. A. Hume, K. J. Stacey, P. R. Young, Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity. Sci. Transl. Med. 7, 304ra142 (2015).
3. P. R. Beatty, H. Puerta-Guardo, S. S. Killingbeck, D. R. Glasner, K. Hopkins, E. Harris, Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination. Sci. Transl. Med. 7, 304ra141 (2015).
4. D. A. Muller, P. R. Young, The f avivirus NS1 protein: Molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker. Antiviral Res. 98, 192-208 (2013).
5. A. L. Rothman, Immunity to dengue virus: A tale of original antigenic sin and tropical cytokine storms. Nat. Rev. Immunol. 11, 532-543 (2011).
6. P. R. Young, P. A. Hilditch, C. Bletchly, W. Halloran, An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients. J. Clin. Microbiol. 38, 1053-1057 (2000).
7. J. H. Amorim, R. P. Alves, S. B. Boscardin, L. C. Ferreira, The dengue virus non-structural 1 protein: Risks and benefts. Virus Res. 181, 53-60 (2014).
8. E. A. Henchal, L. S. Henchal, J. J. Schlesinger, Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus. J. Gen. Virol. 69, 2101-2107 (1988).
9. J. J. Schlesinger, M. W. Brandriss, E. E. Walsh, Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1. J. Gen. Virol. 68, 853-857 (1987).
10. S. R. Fry, M. Meyer, M. G. Semple, C. P. Simmons, S. D. Sekaran, J. X. Huang, C. McElnea, C. Y. Huang, A. Valks, P. R. Young, M. A. Cooper, The diagnostic sensitivity of dengue rapid test assays is signif cantly enhanced by using a combined antigen and antibody testing approach. PLOS Negl. Trop. Dis. 5, e1199 (2011).